Texas Permanent School Fund Corp Has $4.66 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Texas Permanent School Fund Corp cut its position in HCA Healthcare, Inc. (NYSE:HCA) by 37.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,162 shares of the company’s stock after selling 7,225 shares during the period. Texas Permanent School Fund Corp’s holdings in HCA Healthcare were worth $4,659,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in shares of HCA Healthcare during the second quarter worth approximately $1,152,408,000. Price T Rowe Associates Inc. MD raised its holdings in HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after buying an additional 1,091,416 shares during the last quarter. Viking Global Investors LP grew its holdings in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares during the last quarter. Abdiel Capital Advisors LP acquired a new stake in shares of HCA Healthcare in the 1st quarter worth about $164,835,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in HCA Healthcare during the 2nd quarter worth approximately $109,337,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Zacks Research lowered HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Stephens increased their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a report on Monday, October 27th. UBS Group upped their price objective on shares of HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Cowen restated a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, Sanford C. Bernstein reiterated a “market perform” rating and set a $417.00 price target on shares of HCA Healthcare in a report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $475.95.

Insider Buying and Selling

In related news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 0.4%

NYSE:HCA opened at $471.55 on Thursday. The firm’s 50 day moving average is $468.00 and its 200 day moving average is $415.82. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $520.00. The stock has a market capitalization of $107.60 billion, a PE ratio of 18.23, a price-to-earnings-growth ratio of 1.39 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. During the same period in the previous year, the company posted $4.90 earnings per share. The business’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.